Rhythm Pharmaceuticals Director, Publications and Conference Strategy in Boston, Massachusetts
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Working at Rhythm means that you are part of a team that?s passionate about transforming the lives of people living with rare genetic disorders of obesity. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.
Reporting into the Head of Medical Communications, the successful candidate will be responsible for interacting with various investigators, internal authors, and vendors to lead publications strategy and execution while ensuring compliance with good publication practices. In addition, given the intertwined nature of data presentations and conferences, as well as the medical story that encompasses both, the candidate will also lead conference strategy, planning, and execution. This is a position that will allow the successful candidate to perform a wider scope of interrelated medical communication activities and potentially broaden their experience.
Responsibilities and Duties
Work with internal and external authors in facilitating the development of global publications including abstracts, posters, oral presentations, and manuscripts.
Lead cross-functional publications efforts to ensure timely publication of data that are aligned with medical strategy, including audiences/conferences of interest.
Coordinate medical writing with external vendor to ensure high quality before publications are sent for broader review.
Ensure consistent adherence to established Rhythm publication process in accordance with good publication practices.
Develop, manage, and execute strategic conference plans across all programs to support and complement publication plans and educational initiatives.
Oversee development of materials for booths, sponsored symposia, advisory boards, and resources for Medical Science Liaisons.
With vendor support, compile and maintain a database of essential information for each conference to facilitate discussions about choice of conference and planning of activities/abstract submissions.
Continually evaluate conferences at which Rhythm will have most impact, and make recommendations to colleagues regarding activities that may be most worthwhile at each event (e.g., data presentation, symposium, booth, sponsorship, etc.)
Plan, schedule, and lead pre-conference trainings, in part to ensure conference activities are compliant with company policies and guidelines.
With assistance from Field Medical and others, cover poster and scientific sessions at select medical conferences and write debriefs.
Ensure publication and conference activities are aligned with corporate and medical/scientific story.
Manage budgets for publications and conferences.
Qualifications and Skills
Advanced degree, doctorate level (PharmD or Ph.D.) preferred but not required.
Approximately 10 years of relevant Medical Communications or related experience.
Proven ability to effectively collaborate and influence decision-making across multiple levels of an organization, including senior leadership, as well as with KOLs.
Excellent written and communication skills.
Has attention to detail and excellent communication and project management skills
Team player willing to roll up sleeves and bring expertise to other departments as needed.
Willing and able to travel for medical conferences as necessary.
This role is based in our Corporate office in Boston, Massachusetts. Candidates applying must be willing and able to be in the Boston office once it is safe to do so, per State and Federal COVID-19 guidelines.
More about Rhythm
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. The company is targeting the melanocortin-4 receptor (MC4R) pathway that is impaired due to genetic variants. This is a key biological pathway that regulates weight and hunger. A central element of Rhythm?s mission is to improve the understanding of these disorders and develop management strategies for patients who have no treatment options available to them. Rhythm was founded in 2008 and is based in Boston, MA. The company?s clinical development program is currently focused on several rare genetic disorders of obesity, all driven by genetic variants in the MC4R pathway. For healthcare professionals, please visit www.UNcommonObesity.com for more information. For those who may be affected or would like to learn more, visit www.LEADforRareObesity.com for more information.